Nonsteroidal FXR Ligands: Current Status and Clinical Applications
Handbook of experimental pharmacology2019Vol. 256, pp. 167–205
Citations Over TimeTop 1% of 2019 papers
Related Papers
- → Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis(2016)82 cited
- → Bile Acids and the Gut Microbiome as Potential Targets for NAFLD Treatment(2018)15 cited
- → Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis(2024)4 cited
- Gene expression profiling in human precision-cut liver slices upon treatment with the FXR agonist obeticholic acid [human](2016)
- Farnesoid X Receptor (FXR) Agonist Obeticholic Acid (OCA) Restores Liver Regeneration after Partial Hepatectomy in Bile Acid Deprived Rats but Does Not Overdrive Natural FXR Activation in the Physiologic Process of Liver Regeneration(2018)